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Dietary composition can impact colonization and composition of gut microbiota.
The first aim of this dissertation was to evaluate the effect of dietary Se deprivation, sex
and, aging on taxonomic composition of gut microbiota in mice. We have previously
shown that long-term dietary Se deprivation promotes health span deteriorate including
type-2 diabetes like symptoms in later state Terc-/- mice carrying humanized telomeres. In
the present study, the data suggested that the dietary Se deprivation and aging
significantly and comparably altered the gut microflora composition. The ratio of
Firmicutes/Bacteroidetes was decreased by dietary Se deprivation or aging in both sexes.
Abundance of selective gut bacteria genus was associated with dietary Se status and
aging as evidenced by heat map and principal coordinate analyses. Moreover, the
abundance of Akkermensia muciniphila, a bacterium in association with obesity, differed
by Se-deprivation, aging and sex. Taken together, changes in gut microbiota composition
by dietary Se deprivation may accelerate mouse aging in a sex-specific manner.
The second aim of this dissertation was to investigate the effects and underlying
mechanism of fecal fermentation of non-digestible fibers isolated from common beans on

adipocyte differentiation and fat accumulation to elucidate the cellular mechanisms.
Treatment of 3T3-L1 murine preadipocytes with fermented product resulted in a
reduction of triglyceride accumulation in a dose- and time-dependent manner. The
fermentation product exhibited anti-adipogenic effects through suppression of the
adipogenesis-associated key transcription factors or activators peroxisome proliferatoractivated receptor gamma (Ppar gamma), CCAAT enhancer-bind protein alpha (C/ebp
alpha) and fatty acid binding protein 4 (Fabp4). Moreover, the mRNA expression
lipolytic genes including peroxisome proliferator-activated receptor delta (Ppar delta)
and mitochondrial uncoupling protein 2 (Ucp2) were induced by the fermentation
products of non-digestible fiber isolated from common beans counteract adipogenesis
through regulation of key targets.
Altogether, optimizing gut microbiota by nutritionally adequate level of dietary
Se and non-digestible fiber appears to represent a promising strategy to control or prevent
early onset of aging and age-related metabolic diseases.
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INTRODUCTION
1.1

Roles of microbiota in health and chronic diseases
Our gut harbors a complex community of over 100 trillion microbial cells, which

influence human physiology, metabolism, nutrition and immune function. The disruption
of gut microbiota has been linked with gastrointestinal conditions such as inflammatory
bowel disease and obesity. Various functions of the gut are regulated by sophisticated
interactions among its functional elements, including microbiota. Gut microbiota play
important metabolic and physiological roles, including amino-acid synthesis, absorption
of dietary fats and fat-soluble vitamins prevention of pathogenic colonization. Besides,
gut microbiota help the host to eliminate calories from indigestible complex
carbohydrates and plant polysaccharides via enzymes that are not encoded within the
human genome (1). Non-digestible carbohydrates are fermented by colonic microbes,
leading to the production of short-chain fatty acids (SCFAs) such as butyrate, which may
explain their importance in the regulation of fat accumulation and the subsequent
development of obesity-related diseases. Thus, gut microbiota serves as a crucial
mediator of obesity. In addition, gut bacteria play an important role in the host immune
system, modulation of inflammatory processes, extraction of energy from the diet of the
host, and alterations of human gene expression. Dietary modulation of the human colonic
microbiota has been shown to confer a number of health benefits to the host. Simple
1

therapeutic strategies through gut microbiota attenuating progression of chronic lowgrade inflammation and insulin resistance are promising to prevent or slow down the
development of diabetes in humans.
1.1.1

Influence of diet on the gut microbiota
Diet has recently been shown to strongly and rapidly influence the composition of

gut microbiota. In a controlled-feeding study with humans consuming a high-fat/lowfiber diet or a low-fat/high-fiber diet, notable changes were found in gut microbiota,
highlighting the rapid effect of a diet on the intestinal microbiota (2, 3). Such dietary
change is also known to induce adiposity, resulting in altered microbiome gene
expression. The impact of gut microbiota is transmissible as evidenced by microbiota
transplantation. Mice on a “Western diet (high fat and low fiber diet)” experience
increased abundance of bacteria of the phylum Firmicutes and decreased abundance of
those of the phylum Bacteroidetes (4). In addition, dietary changes (high- vs low-fat diet)
could explain 57% of the total structural variation in gut microbiota whereas changes in
genetics (ob/ob mice vs wild-type mice) accounte for no more than 12% (5).
Interestingly, De Filippoetal et al. (3) found that European children have a microbiota
depleted of Bacteroidetes and enriched in Enterobacteriaceae compared to rural African
children, the authors suggest that such changes are attributed to low dietary fiber intake
by Europeans (6). These authors postulated that gut microbiota coevolved with the plantrich diet in African children, allowing them to maximize energy extraction from dietary
fiber such that they are protected from inflammation and non-infectious intestinal
diseases (3). Another study demonstrated that vegetarian diets decrease the amount and
change the diversity of Clostridium cluster IV and Clostridium clusters XIV and XVII
2

(7). Moreover, supplementation of oligofructose in humans increases bifidobacteria
content in the gut, reduces inflammatory status such as pro-inflammatory cytokines in
plasma and adipose tissue (8).
1.1.2

Gut microbiota and obesity
Overweight and obesity are metabolic disorders that have increased all over the

world. Many studies link gut microbiota to the development of metabolic disorders.
Studies have shown that obesity is associated with a shift of the dominant phyla in the gut
and with modifications in a significant reduction in Bacteroidetes and a corresponding
increase in Firmicutes (9). A shift in the relative abundance observed in these phyla is
associated with increased capacity to harvest energy from food and with increased lowgrade inflammation. Moreover, gut microbiota have also been shown to decrease the
production of fasting-induced adipose factor, which is a circulating inhibitor of
lipoprotein lipase, such that the storage of liver-derived triglycerides is increased (10).
Indeed, characterization of the gut microbiome in obese mice (ob/ob) and their lean (+/and +/+) littermates showed that the obesity-associated microbiome harbors a substantial
increase in expression of enzymes involved in breakdown of dietary polysaccharides
when compared with the lean microbiome. In agreement with this, a reduced calorie
content in the feces of obese mice as compared with their lean counterparts highlight
increased capacity of the obese microbiome for energy extraction from the diet (11). The
increase in polysaccharide-degrading enzymes found in the obese microbiome is also
linked to increased fat deposition are evidenced by a microbiota transplantation model.
Transfer of the microbiota harvested from the intestine of conventionally raised,
genetically obese (ob/ob) mice into germ-free mice results in a transfer of the obese
3

phenotype. Additionally, germ-free mice conventionalized with microbiota from donor
mice with obesity induced by a “Westernized” diet also show increased body fat
deposition. Interestingly, mice that are fed a Westernized diet but remain germ-free are
protected from the obese phenotype (12). Studies conducted in germ-free mice support a
role for the gut microbiota in the harvest and storage of energy derived from ingested
nutrients. Backhed et al. (13) have demonstrated that the introduction of gut microbiota
from conventionally raised mice into germ-free mice results in a 60 % increase in body
fat and insulin resistance within 2 weeks despite reduced chow consumption (by 29 % )
and increased activity (by 27 % ) compared with germ-free mice. Take together, these
findings suggest that the gut microbiota are active players in the development of obesity.
1.1.3

Gut microbiota in type 2 diabetes
Type 2 diabetes (T2D), an auto-inflammatory disorder, is characterized by insulin

resistance in peripheral tissues during the early stage of pathogenesis followed by beta
cell failure with pathologies such as decreased islet size and insulin production (14). A
human metagenome-wide association study shows significant correlations with specific
gut microbes, bacterial genes and metabolic pathways in T2D patients. Studies in
different populations have also shown that diabetic gut microbiota have lower
concentrations of two butyrate-producing bacteria, Roseburia intestinalis and
Faecalibacterium prausnitzii both), and higher levels of Lactobacillus gasseri,
Streptococcus mutans and Clostridiales members. In addition, changes in the amount of
Bifidobacterium, Lactobacillus, and Clostridium as well as a reduced Firmicutes to
Bacteroidetes ratio in gut microbiota have also been recently reported in type 1 diabetic
children (15). Various mechanisms have been proposed to explain the influence of the
4

microbiota on insulin resistance and T2D, including metabolic endotoxemia,
modifications in the secretion of the incretins and butyrate production.
Lipopolysaccharides (LPS) are endotoxins commonly found in the outer
membrane of Gram-negative bacteria that cause metabolic endotoxemia, which is
characterized by the release of pro-inflammatory molecules (16). A rise in LPS levels has
been observed in human subjects or mice with increased fat intake (17, 18). Furthermore,
ob/ob mice even on a normal diet show elevated LPS levels (19). Thus, elevated LPS
levels may be positively associated with insulin resistance through changes in the
proportion of Gram-negative bacteria or permeability of the gut. Moreover, LPS-infused
mice have the similar phenotype as compared to mice induced by high fat diet, both of
which display fasted glycemia and insulinemia and increased whole-body, liver, and
adipose tissue weights (20). Most importantly, knockout of a LPS receptor CD14 renders
the mice resistant to LPS and high fat diet and the associated metabolic disorders (19).
This finding demonstrates that metabolic endotoxemia dysregulates the inflammatory
tone and triggers body weight gain and diabetes. Cani et al. (18) have reported that
modulation of the intestinal microbiota by using prebiotics to increase short chain fatty
acid (SCFA), lowers high-fat diet-induced LPS endotoxemia, and inflammation and may
provide optimized intestinal integrity metabolism in obese mice
1.1.4

Gut microbiota and neurodegeneration
Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the two most

common neurodegenerative disorders in humans. In both diseases, a neuropathological
hallmark is the accumulation of misfolded neuronal proteins in the brain. It is, however,
not known what initiates this process. In AD, deposition of aggregates of amyloid-β
5

peptide and tau impairs cognitive function in central nervous system (CNS). Bacterial
infection is known to induce amyloid-β peptide oligomerization, suggesting that
infection-induced amyloidosis may drive AD (21). Aside from externally acquired
microbes, Harach et al. (22) have demonstrated APPPS1-Tg mouse model of AD derived
displays reduced cerebral and serum amyloid-β levels under GF conditions. These results
are consistent with reduced plaque deposition in another mouse model of AD
(APPSWE/PS1∆E9 mice) being treated with broad-spectrum antibiotics (23). In support
of a role for intestinal microbes in promoting Alzheimer’s disease, members of the host
microbiota can regulate amyloidosis by producing their own amyloid peptides (24). PD is
a neurodegenerative motor disorder that is frequently associated with impaired gastric
motility (25) and elevated levels of α-synuclein in the intestine (26), raising the
possibility that the intestinal environment regulates the development of disease
symptoms. Besides, PD patients exhibit increased intestinal permeability and colonic
inflammation (27, 28). Several studies have demonstrated that pro-inflammatory factors
in association with chronic GI diseases can induce brain inflammation, death of
dopaminergic neurons and parkinsonism (29, 30). Moreover, two studies have revealed
that fecal microbiota from PD patients exhibit reduced abundance of Prevotellaceae
compared to healthy controls (31, 32). Prevotellaceae bacteria as commensals are
involved in mucin synthesis in the gut mucosal layer and production of neuroactive
SCFA through fiber fermentation (33). Thus, the reduced abundance of Prevotellaceae
could result in decreased mucin synthesis and increased intestinal permeability
exacerbating local and systemic exposure to bacterial antigens and endotoxins, which in
turn would trigger or maintain excessive α-synuclein expression in the colon or even
6

promote its misfolding (28). Altogether, modulation of gut microbiota through
personalized diet or beneficial microbiota intervention is promising treatment of
neurodegenerative diseases.
1.2

Nutritional selenium
Selenium (Se) is an essential trace element used for biosynthesis of selenoproteins

and is acquired either through diet or cellular recycling mechanisms. Foods rich in Se
include seafood, organ meats, dairy products, grains, cereals, and Brazil nuts, albeit Se
concentrations in plants are dependent on the Se levels of the soil that the plants grow on
as well as the plant’s capacity to uptake Se. Thus, populations that live in areas with low
soil Se are at risk for Se deficiency. Complications from severe Se deficiency include
Keshan disease (34), a cardiomyopathy (35), and Kashin-Beck disease carrying bone
degeneration (36). Low Se levels have also been implicated in disease of the brain, the
immune system, thyroid, male reproduction (37) and cancer. The current daily
recommended value of Se for adults is 55 µg/day in the United States, a value based on
maximal glutathione peroxidase activity (38). The dose range for Se that is beneficial for
human health is fairly narrow, and has been described as a U-shaped curve.
1.2.1

Selenoprotein
By decoding the stop codon UGA, selenoproteins incorporate Se in the form of

selenocysteine at translational level. Based on their structures and functions, the 25
mammalian selenoproteins are classified as glutathione peroxidases (GPX1-4 and 6),
thioredoxin reductases (TXNRD1-3), iodothyronine deiodinases (DIO1-3), the Rdx
family of selenoproteins (SELENOW, SELENOT, SELENOH, and SELENOV),
7

thioredoxin-like fold endoplasmic reticulum proteins (SELENOF and SELENOM), or
others (methionine-R-sulfoxide reductase-1, selenophosphate synthetase-2 (SEPHS2),
SELENOI, SELENOK, SELENOS, SELENOO, SELENON, and SELENOP). All
functionally characterized selenoproteins are known as redox enzymes. Some
selenoproteins are directly involved in Se metabolism. For example, SEPHS2 generates
monoselenophosphate from selenide and ATP, and SELENOP transports Se from liver to
other tissues. Physiological and molecular roles of selenoproteins have been
comprehensively reviewed (39). Interestingly, although selenoproteins are generally
considered to be beneficial, paradoxical roles of selenoproteins such as GPX1-3,
TXNRD1, and SELENOP in cancer and diabetes have also been reported (40).
In addition to the UGA codon, translational incorporation of selenocysteine
requires the cis-acting selenocysteine insertion sequence (SECIS) at the 3’-untranslated
region of selenoprotein mRNAs, as well as trans-acting factors including SECIS-binding
protein 2 (SBP2, encoded by SECISBP2) and selenocysteinyl tRNA (encoded by TRSP
with additional modifications). The synthesis of mature selenocysteinyl tRNA requires
the sequential enzymatic reactions of seryl-tRNA synthetase, phosphoseryl-tRNA[Ser]Sec
kinase, and selenocysteine synthase (encoded by SEPSECS) on the TRSP gene product.
The essentiality of these 25 selenoproteins is exemplified by the fact that Trsp-/- mice are
embryonically lethal (41). Recent advances have identified a couple of human mutations
in genes necessary for selenoprotein synthesis, including those on TRSP (42), SECISBP2
(43), or SEPSECS (44, 45). Phenotypes and Se markers of these mutations in humans are
summarized in Table 1.1. Consistent with their essentiality in selenoprotein synthesis,

8

these mutations result in significant decrease in plasma Se concentrations and tissue
selenoprotein expression (Table 1.1).
Tissue Se concentrations differ, ranging from 1.5 nmol/g in brain or muscle to 1018 nmol/g in kidney, liver, and testes (46). GPX1 accounts for 58% of total liver Se in
mice (47), and the two Se transporters, GPX3 and SELENOP, altogether represent 54%
of total plasma Se in healthy humans (48). In addition to selenoproteins, Se can exhibit
specifically and post-translationally in Se-binding proteins presumably through their
structural configurations (49), as well as non-specifically by replacement of sulfur with
Se in methionine or cysteine residues of proteins (Figure 1.1). Speciation and doses of Se
affect its incorporation into proteins.
1.2.2

Selenium and metabolic disease
Metabolic syndrome is a multiplex risk factor that is initiated by insulin resistance

accompanying abnormal adipose deposition and function. It is a risk factor for
cardiovascular disease, as well as diabetes, fatty liver, and several cancers.
The influence of dietary Se, on carbohydrate and lipid metabolic disorders
remains unresolved. In rodents, Se deficiency increases plasma cholesterol levels (50),
while supplementation of supranutritional Se (0.4 ppm selenite) induces insulin resistance
(51). In vitro studies the mouse insulinoma derived β-cell line, MIN6, have demonstrated
increased insulin content and secretion in response to Se treatment, supporting to the
hypothesis that Se is protective against T2D in pancreatic cancer (52). Selenoproteins act
mostly in redox-dependent reactions and have been demonstrated to be involved in
energy metabolism through various mechanisms. Examples include 1) reduction of
oxidative stress by glutathione peroxidases and thioredoxin reductases (53), 2) regulation
9

of thyroid hormones activity by iodothyronine family (54), 3) disruption of pancreatic
insulin secretion (55), and 4) regulation of phosphorylation of key elements of energy
metabolic pathways, such physiological targets include insulin signaling inhibitor protein
tyrosine phosphatase 1B (56), a modulator of glucose and fatty acid metabolism and
mitochondrial function, adenosine monophosphate-activated protein kinase (AMPK)
(57), and a regulator of satiety hormone leptin (58). Thus, selenoproteins appear to play a
key role in lipid metabolism.
1.3

Common bean (Phaseolus vulgaris)
Common bean (Phaseolus vulgaris) is the most important edible legume in the

world. It provides 15% of the protein and 30% of the caloric requirement to the world's
population, and represents 50% of the grain legumes consumed worldwide (59). A large
variability exists in common bean seeds. Color and size are the two important quality
characteristics for the consumers. Seed size and weight depend on genetic variations,
cultivar and environmental conditions (60). The seed color of beans is determined by the
presence of polyphenolic compounds (61, 62). Important biological activities of common
beans have been described for fiber, polyphenolic compounds, lectins, trypsin inhibitors,
and phytic acid such benefits include enhancement of the bifidogenic effect (63),
antioxidant effects(64), anti-carcinogensis (65), anti-adipogenesis (66), and antiproliferation on transformed cells (67). Moreover, carbohydrate is the major component
in legumes (55% to 65%); of these, starch (22% to 45%) and dietary fiber are the major
constituents, in addition to a small but significant amount of oligosaccharides (68).

10

1.3.1

Non-digestible fiber
Dietary fiber is a plant-based material in the diet and resistant to enzymatic

digestion. Well known dietary fiber includes cellulose, noncellulosic polysaccharides
such as hemicellulose, pectic substances, gums, mucilages and a non-carbohydrate
component lignin (69). Diets rich in fiber include beans, cereals, nuts, fruits and
vegetables, all of which have a positive effect in health since their consumption is
causative to several diseases (70). The beneficial effects of dietary fiber include increased
the volume of fecal bulk, decreased the time of intestinal transit and cholesterol and
glycaemic levels. Trapping substances can be dangerous for the human organism to dead
with mutagenic and carcinogenic agents (71). Most commonly consumed foods are low
in dietary fiber. Generally, a serving of food contains 1 to 3 g of fiber. Higher fiber
contents are found in foods such as whole grain cereals, legumes, and dried fruits.
According to the 2015 Dietary Guidelines for Americans from U.S. Department of
Agriculture offered by human should consume 14 g of fiber for every 1000 calories.
Based on this, males should aim for 38 grams of fiber per day and 25 grams for females.
However, most Americans typically consume about half of the recommended amounts of
fiber each day (about 15 g/day).
1.3.2

Benefits of dietary fiber on human health
Fermentable fibers may provide a number of health benefits by altering the

composition of the intestinal flora. Prebiotics are non-digestible substances that provide a
beneficial physiological effect to the host by selectively stimulating the favorable growth
or activity of a limited number of indigenous bacteria. This generally refers to the ability
of fiber to increase the growth of bifidobacteria and lactobacilli, which are considered
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beneficial to human health. Benefits of prebiotics include improvement in gut barrier
function and host immunity, reduction of potentially pathogenic bacteria subpopulations
(e.g., Clostridia), and enhanced SCFA production. Studies have provided evidence that
inulin and oligofructose, lactulose, and resistant starch meet all aspects of the definition,
including the stimulation of Bifidobacterium, a beneficial bacterial genus (72). Other
isolated carbohydrates and carbohydrate-containing foods, including
galactooligosaccharides, transgalactooligosaccharides, polydextrose, wheat dextrin,
acacia gum, psyllium, banana, whole grain wheat and whole grain corn also have
prebiotic effects.
Increasing fiber intake is associated with a wide range of health benefits. First,
soluble fibers have been shown to increase the rate of bile excretion therefore reducing
serum total and LDL cholesterol (73). Second, short chain fatty acid production via
fermentation, specifically propionate, has been shown to inhibit cholesterol synthesis
(74). Third, dietary resistant starch, when fermented in the large intestine, produces
glucagon-like peptide and peptide YY (75). These two gut hormones induce satiety to
regulate energy intake, thus enhancing weight loss or maintenance of a healthier body
weight. Fourth, dietary fiber has been shown to lower the risk for type 2 diabetes, an
accelerated secretion of glucose-dependent insulintropic polypeptide (GIP) as observed
directly after the ingestion of an insoluble fiber in healthy women (76). GIP is an incretin
hormone, which stimulates postprandial insulin release.
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1.4

Figures and tables

Table 1.1

Human diseases known to be attributed to mutations in genes in association
with selenoprotein synthesis.

Genes

Mutations

Phenotypes

TRSP

Point mutation

Abdominal pain,
fatigue, muscle
weakness, and low
plasma levels of
selenium

SECISBP2

Heterozygous for
paternally inherited
frameshift/premature
stop mutation;
maternally inherited
missense mutation

SEPSECS

Missense mutation

Missense mutation;
nonsense mutation

Plasma
selenium
(µmol/L)
0.28

Selenoprotein
deficiency

SELENOP,
GPX3 in plasma.
GPX1 in
fibroblasts.
SELENOW
mRNA in
fibroblasts.
Azoospermia,
0.11 - 0.14 SELENOP and
muscular dystrophy,
GPX3 in plasma;
photosensitivity,
mGPX4,
abnormal cytokine
TXNRD3 and
secretion, and
SELENOV in
telomere shortening
seminal plasma;
and replication
SELENON,
stress in T
MSRB1, and
lymphocytes
GPX1 protein,
and SELENOH,
SELENOW, and
SELENOT
mRNAs in
fibroblasts.
Autosomal
Not reported Not reported
recessive symptoms
of progressive
cerebellocerebral
atrophy
Cortical laminar
Not reported GPX1, GPX4
necrosis, loss of
TXNRD1 in
myelin and neurons,
brain
and astrogliosis
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Figure 1.1

The three forms of selenium-containing proteins.

Selenium exists in proteins in the form of selenoproteins, selenium-binding proteins, and
cysteine and methionine residues on any proteins. They are categorized by the presence
of in-frame UGA codon and specificity in binding selenium. A small portion of body
selenium is present in low molecular weight, non-protein forms.
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CHAPTER II
EFFECT OF LONG-TERM DIETARY SELENIUM DEPRIVATON, SEX AND
AGING ON GUT MICROBIOTA IN SHORT TELOMERE MICE
2.1

Abstract
Dietary composition can impact on colonization and composition of gut

microbiota. Dietary Se deficiency differentially decreases selenoprotein expression in a
tissue- and selenoprotein-specific manner. The diversity of microbiota is known to be
decreased as a result of dietary Se deficiency in mice. Moreover, microbiota may
compete with the host for selenium when its availability becomes limiting. Gpx1-/-Gpx2-/mice display microflora-associated intestinal cancers in association with increased
intestinal oxidative stress and inflammation. Se-deficient short telomere mice exhibit
early onset of age-related degeneration including skin aging, osteoporosis, and type-2
diabetes like symptoms, of which males aged earlier than females. This study aim is to
determine the effect of dietary Se deprivation and sex on taxonomic composition of gut
microbiota during mouse aging. Our data suggested that the dietary Se deprivation and
aging significantly and comparably altered the gut microflora composition. The ratio of
Firmicutes/Bacteroidetes was decreased by dietary Se deprivation or aging in both sexes.
The abundance of selective gut bacteria genus was associated with dietary Se status and
aging as evidenced by heat map and principal coordinate analyses. Moreover, the species
of Akkermansia muciniphila showed the significantly difference between the sexes.
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Taken together, changes in gut microbiota composition by dietary Se deprivation may
accelerate mouse aging. Our results verify the findings of microbiome shifts and changes
in taxonomy and function with relevance to aging and selenium deprivation. Particularly,
the abundance of Akkermansia muciniphila show the significantly difference between
dietary Se manipulation, aging and sex, suggesting the sex hormone also influence the
composition of microbiota. Finally, proposing nutritional Se can maintain healthy
microbiota during the aging process.
2.2

Introduction
The microbial community in the gastrointestinal tract is widely recognized as a

key component of gut homeostasis that impacts optimal health. While the composition
and abundance of gut microbiota remains stable over time in healthy adults, there are
significant shifts upon exiting infancy and entering extreme old age (77-79). In
particular, a composition shift from Firmicutes to Bacteroidetes during the aging process
has been consistently reported in mice and humans (80). In addition to such temporal
patterns during lifespan, changes in gut microbiota have been linked to temporary event
such as antibiotics treatment and to dietary choices and defective immunity chronically.
Furthermore, the calorie restriction-induced changes in the gut microbiota are correlated
with reduced antigen load to the host, contributing to lifespan extension by calorie
restriction (81).
Insufficient or excess intake of selenium (Se) compromises optimal health and
contributes to age-related degeneration (82, 83). The reciprocal interaction of Se, a trace
element necessary for all the three domains of life, with gut microbiota can have positive
or negative physiological consequences. Selenoproteins, the majority of which carry
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antioxidant activities, account for the physiological function of body Se (39). The fact
that 21.5% of sequenced bacteria express selenoproteins suggests competitions between
gut microbiota and host for Se, especially when this element is insufficiently available
(84). Compared to germ-free mice under Se insufficiency (0.086 ppm), conventional
mice display decreased Se concentration in the plasma and the cecum, intestinal Gpx1
and Gpx2 mRNA expression and glutathione peroxidase activity, and intestinal
thioredoxin reductase activity (85). Furthermore, although plasma Se concentration is
not affected, gut microbiota down-regulates Gpx1 and MsrB1 in liver and kidney of Seadequate mice but elevates selenoprotein P protein expression, a major Se transporter, in
plasma (86). Gut microbiota also exacerbates intestinal cancer in Gpx1-/-Gpx2-/- mice
(87), and a health-promoting effect of dietary supplementation of Se-enriched probiotics
has been reported in piglets under stressed conditions (88).
There are differential effects of sex or sex hormones on gut microbiota changes
(89, 90), but how Se, age, and sex interplay on gut microbiota is not known. In this study,
we hypothesized that Se at nutritional level of intake and sex modulate the composition
and abundance of gut microbiota in mice of old age. Metagenomic analyses of bacterial
16S rDNA from mouse feces collected at 18 months and 24 months demonstrated
significant changes by dietary Se deprivation and age in the taxonomic and genetic
composition of the gut microbiota, some of which were differentially affected by sex. In
particular, Akkermensia mucniiphila was the genus that responded to both aging and Se
deprivation the greatest in both sexes.
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2.3
2.3.1

Material and method
Mice and diet.
Terc+/- mice (#004231, the Jackson Lab) were provided by Dr. Mark Mattson at

the National Institute on Aging, USA. The mice had been backcrossed to be >99% pure
C57BL/6 background before being interbred for the generation of Terc-/- short telomere
mice for this study. Mice were kept under aseptic conditions in individually ventilated
cages (up to 4 mice/cage) within an animal room (22C, 12-h dark:light cycle) and had ad
libitum access to foods and sterilized water. The AIN-93G purified diets (Dyets Inc.,
Bethlehem, PA, USA) were stored at -20 C until being used for feeding. The basal (Se-)
diet contains 30% Torula yeast and <0.03 mg/kg Se by analysis (AOAC Method 986.15;
Covance Laboratory, Madison, WI, USA), and was supplemented with 0.15 mg Se/kg
(Se+) as sodium selenite (91). Weanling mice were fed the Se- or Se+ diet until they
were sacrificed or died naturally.
2.3.2

Bacterial genomic DNA extraction and sequencing.
DNA was extracted from fecal sample of mouse using Powerfecal® DNA

Isolation Kit (MO BIO Laboratories, Carlsbad, CA) according to the manufacturer’s
instructions and amplified using universal primers (16S amplicon PCR forward,
TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG;
16S amplicon PCR reverse,
GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAA
TCC) that target the V3~4 regions of bacterial 16S rDNA. The resultant DNA was
quantified by ultraviolet spectroscopy and agarose gel and then stored at –80°C for
further analysis. Individual samples were barcoded by using the Nextera XT Index Kit
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(Illumina, San Diego, CA), pooled to construct the sequencing library, and sequenced
using an Illumina Miseq (Illumina, San Diego, CA) to generate pair-ended 300×300
reads.
2.3.3

Analysis of 16S rDNA sequencing data.
The raw mate-paired fastq files were quality-filtered and analyzed using Miseq

Reporter Software (Illumina) v2.3. The reads were classified against the GreenGenes
database with species-level sensitivity. A total of 34,509,237 high-quality sequences were
acquired from 48 samples with each of the samples containing 732,397 sequences on
average. Principal coordinate analysis (PCoA) showed similarity between normalized
relative abundance of all samples. The PCoA was generated using Classical MDS on a
Pearson covariance distance matrix generated from per-sample normalized classification
abundance vectors. In addition, heat maps were generated using a hierarchical clustering
algorithm to visualize the difference within the data set. The alpha diversity of Shannon
index and Simpson index was calculated at the species-level.
2.3.4

qPCR analysis.
Each quantitative polymerase chain reaction (qPCR) was performed in 25 μl

according to standard procedures using Universal SYBR Green Supermix (Bio-rad,
Hercules, California) and primer sets for Akkermansia muciniphila (F1129,
CAGCACGTGAAGGTGGGGAC; R1437, CCTTGCGGTTGGCTTCAGAT) (92),
Lactobacillus (F157, TGGAAACAGRTGCTAATACCG; R379,
GTCCATTGTGGAAGATTCCC) (93), Escherichia coli (F415,
GGCCTTCGGGTTGTAAAGTA; R659, AGACTCAAGCTTGCCAGTATC),
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Faecalibacterium prausnitzii (F222, AGATGGCCTCGCGTCCGA; R420,
CCGAAGACCTTCTTCCTCC) (94) Roseburia spp. and E. rectale (F,
GCGGTRCGGCAAGTCTGA; R, CCTCCGACACTCTAGTMCGAC) (95) Universal
primers located in highly conserved sequences, but targeting the V4 hypervariable region
of the 16S rRNA genes, were used to quantify total bacteria: V4 (F517,
GCCAGCAGCCGCGGTAA; R805, GACTACCAGGGTATCTAAT). Triplicate qPCR
reactions were analyzed on the ABI 7500 Fast Real-Time PCR System (Life Technology,
Carlsbad, California). Standard curves were created using serial 10-fold dilutions of each
plasmid. The bacterial concentration of each sample was calculated by comparing the
crossing point (Cp) values obtained from the standard curve.
2.3.5

Statistical analysis.
Data are presented as means of 6 samples with the standard deviations (means ±

SDs). Statistical data processing was performed with XLSTAT (Addinsoft USA, New
York, NY). Differences between two groups were assessed using the unpaired two-tailed
Student t test. The results were considered statistically significant when P < 0.05.
2.4
2.4.1

Results
Dietary Se deprivation accelerates age-dependent taxonomic changes in
gut microbiota in both males and females
Consistent with previous studies (81, 96), results from metagenomic sequencing

of 16S rDNA V3-4 region amplicons of fecal samples showed that 97.7% of all aggregate
microbiota composition at phylum level belonged Bacteroidetes, Firmicutes,
Proteobacteria and Verrucomicrobia (Figures 2.1b and 2.1c). In Se-adequate males, there
were increased (P < 0.05) abundance of Bacteroidetes (30 ± 13% vs. 60 ± 8.3%) and
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Verrucomicrobia (0.1 ± 0.3% vs. 9.2 ± 5.7%) from 18 to 24 months of age. Interestingly,
dietary Se deprivation accelerated the age-dependent dominance of Bacteroidetes (30 ±
14% vs. 42 ± 13%) and Verrucomicrobia (0.1 ± 0.3% vs. 4.7 ± 1.9%) at 18 months of age
in the male mice. However, decreased abundance by age and dietary Se deprivation was
observed in the phyla Firmicutes and Proteobacteria in the male mice. A decrease in the
ratio of Firmicutes/Bacteroidetes is an established marker of aging (80). We observed
that such ratio was significantly decreased (P < 0.05) by age, and dietary Se deprivation
accelerated such decline at 18 months of age in both male and female mice (Figure
2.1d). Thus, dietary Se deprivation accelerated the shift of gut microbiota toward an age
setting in both male and female mice.
2.4.2

Quantitative differences between the gut microbiota of diet, age and sex
mice groups
To determine the overall diversity of the microbiota, Bray-Curtis indices were

calculated by principal coordinate analysis that provides pairwise visualization of
dissimilarity between two communities. Results from the beta diversity analyses showed
obvious separation of Se-adequate mice at 18 months of age from the other three groups
that displayed noticeable overlap in both males and females (Figure 2.2a). These results
suggested that age and dietary Se deprivation similarly changed the diversity of gut
microbiota in both male and female mice. To elaborate on this observation, microbial
alpha diversity at species level was assessed by nonparametric Shannon (Figure 2.2b)
and Simpson indices (Figure 2.2c) that represent within-subject variations. In Seadequate mice at 18 months of age, the overall diversity of the microbiota was smaller in
males than in females. In males, there were overall increases in microbial diversity by age
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and dietary Se deprivation in a comparable manner. In sharp contrast, alpha diversity was
similarly decreased by age and dietary Se deprivation in female mice. Altogether, while
the acceleration of age-dependent changes in gut microbial diversity by dietary Se
deprivation occurs in both male and female mice, the formal and latter shows elevated
and decreased diversity, respectively.
Hierarchical clustering of genus-like taxa as illustrated in a heat map showed that
Se-adequate males and females at 18 months of age mice (A, E) tended to group together
and accounted for 68% of cluster 1, whereas they did not have discernable association in
cluster 2 (Figure 2.3). In particular, cluster 1 was characterized by more Proteobacteria,
Clostridium and Lactobacillus and less Bacterodetes, Akkermansia and Clostridium
cluster XIVa.
2.4.3

Dietary Se deprivation and age, but not sex, similarly affect the abundance
of three selenoprotein-rich phyla
Selenocysteine is utilized in 21.5% of all sequenced bacteria, and many gram-

positive bacteria express selenoproteins (97). While 41 ± 8.6% of gut microbiota was
Gram-positive in Se-adequate mice at 18 months of age, the abundance significantly (P <
0.05) decreased to 21 ± 5.8% by age and 24 ± 11% by dietary Se deprivation (Figures
2.4a and 2.4b). Such Se and age effects occurred similarly in both male and female mice.
There are three bacterial phyla known to express relatively higher numbers of
selenoproteins: the gram-positive Clostridia and Actinobacteria and gram-negative
Deltaproteobacteria (84). Thus, we determined the effect of dietary Se deprivation, as
well as age and sex, on the abundance of these three selenoprotein-rich phyla. Dietary Se
deprivation and age significantly (P < 0.05) decreased the abundance of Clostridia and
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Actinobacteria to a comparable extent in male mice, but such effect was marginal or null
in female mice (Figures 2.4c and 2.4d). Surprisingly, the abundance of
Deltaproteobacteria was similarly increased by age and Se deprivation in both male and
female mice, and there was an additively effect of Se and age in female mice (Figure
2.4e). Thus, dietary Se deprivation accelerates age-dependent changes in Gram-positive
bacteria and phyla that are rich in selenoprotein expression in both male and female mice.
2.4.4

A 22-38 fold increase in the abundance of Akkermansia muciniphila by
dietary Se deprivation and age
The relative amounts of Verrucomicrobia were increased marginally by Se

deprivation (P = 0.09) and significantly by aging (P = 0.005) (Figures 2.1b and 2.1c).
Further analyses of the major species of Verrucomicribia, Akkermansia muciniphila,
which has been identified as a mucin-degrading bacteria that resides in the mucus layer
(98), showed a 38-fold increase by age in Se-adequate mice and 22-fold by dietary Se
deprivation in 18-month males (Figure 2.5a). In females, there is a 2.4-fold increase by
age in both Se-deficient and Se-adequate mice, but dietary Se deficiency did not affect
the relative abundance of Akkermansia muciniphila in females. Overall, Akkermansia
muciniphila is more abundant (P < 0.05) in females than in males. The age-, Se-, and sexdependent changes of Akkermansia muciniphila levels were confirmed by qPCR analyses
(Figure 2.5b). Altogether, dietary Se deprivation accelerated the age-dependent increase
of the abundance of Akkermansia muciniphila in male but not in females.
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2.4.5

Specific genera affected by dietary Se deprivation or aging
Previous studies have observed decreased abundance of gut microbiota producing

SCFA and increased facultative anaerobes and opportunistic pathogens during the aging
process, likely leading to inflammation and overall frailty (77, 99, 100). While the
abundance of the SCFA-producing Clostridium clusters IV and XIVa members were not
affected by dietary Se deprivation or age (Shuttleworthia, Lachnospira,
Pseudobutyrivibrio, Blautia, Ruminococcus, Faecalibacterium, Roseburia, Butyrivibrio
,Catonella and Coprococcus, data not shown). However, we used the qPCR to further
confirm the results found that the Faecalibacterium prausnitzii and Roseburia spp./E.
rectale significantly decrease by Se-deprivation and aging (Table 2.1). To associate the
presence of SCFA-producing bacterial communities, including the Akkermansia
municiphila with the effective increase in the concentration of SCFAs in fecal samples,
we determined the level of acetic, propionic, butyric acid in the fecal sample using GCMS analysis (Figure 2.6a). It was remarkable that content of total SCFAs, acetic,
propionic, butyric acid were significantly higher by dietary Se deprivation and age in
both male and female mice (P < 0.05). Furthermore, the amounts of total SCFAs were
richer in males than females (P < 0.05). In contrast, the abundances of some potentially
pathogenic intestinal microbes, including Escherichia and Enterobacter were
significantly decreased (P < 0.05) by both dietary Se deprivation and age (Figure 2.6b).
Similar results were observed in the female mice. In addition, the probiotic
Bifidobacterium and Lactobacillus were previously shown to decrease by age (81, 99).
Here we demonstrated that the relative abundance of Bifidobacterium was significantly
decreased (P < 0.05) by dietary Se deprivation and age in male, but not female mice
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(Figures 2.7a). Although a similar trend was observed in Lactobacillus, but no statistical
difference was detected in male mice (Figure 2.7b), which was in line with the qPCR
data (Table 2.1).
2.5

Discussion
In this report, we provide gut microbiota evidence demonstrating parallel

responses to aging under Se adequacy and to dietary Se deprivation at 18 months of age
in mice, strongly suggesting that dietary Se deprivation accelerates age-dependent
changes in abundance, diversity and composition of gut microbiota. Furthermore, Se and
aging modulate gut microbiota in a sex-specific manner.
The ratio of the two most dominant phyla in the gut, Bacteroidetes and
Firmicutes, offers informative markers for aging and some age-related conditions. A
large phylum shift from Firmicutes to Bacteroidetes has been shown in aged mice (81)
and humans (80). Similarly, Claesson et al. (78) have indicated that the
Firmicutes/Bacteroidetes ratio declines in elderly people when compared to young adults.
From the perspective of taxonomic and functional composition, the gut microbiota might
be linked and contribute to complex diseases. For example, type 2 diabetes (T2D) in
humans is associated with compositional changes in intestinal microbiota. The proportion
of the phylum Firmicutes and the class Clostridia in the gut of T2D patients are
significantly reduced and the ratio of Firmicutes to Bacteroidetes is negatively correlated
with plasma glucose concentration (101, 102). In addition, several studies have indicated
that weight loss by dietary manipulation or gastric bypass surgery decreases the ratio of
Firmicutes to Bacteroidetes (103, 104), which was in line with our results in that the Sedeprivation mice displayed rapid declines in body weight after 15 months of age (105).
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Besides, we show that the ratios of gram-negative to gram-positive bacteria are increased
by Se deprivation and aging. Because lipopolysaccharide (LPS), a potent stimulator of
inflammation and endotoxaemia (19), is the main component of the outer membranes of
gram-negative bacteria, LPS levels may be enhanced and inflammatory responses are
triggered in the gut, contributing to the development of diabetes, which was associated
with our result in that the Se-deprivation exacerbate age-dependent metabolic disorders,
including glucose intolerance and insulin resistance in G3 Terc-/- mice (105). Here, our
data indicated that dietary Se deprivation is associated with gut microbial compositional
changes that may impact health conditions during the aging process.
The gut microbial diversity is regarded as a health indicator. It has been reported
that reduced diversity in gut microbiota is associated with several human diseases such as
obesity, inflammatory bowel disease, and infectious diseases undergoing antibiotic
treatment (99, 104). Additionally, microbial diversity is reduced in elderlies. Kasaikina et
al. have showed that mice on a 2 months of Se deprivation diet display a decrease in the
bacterial diversity compared with 0.1 ppm Se diet in conventional but not
conventionalized germ-free males (86). However, dietary Se deprivation and age increase
microbial diversity in gut of Terc-/- males after 24 months of dietary manipulation
compared with 18 months. Such diversity change is greater in females than in males in
Se-adequate mice at 18 months of age. Gut microbiota abundance and composition differ
in males and females and by castration, suggesting that sex hormones may affect gut
microbiota (89). While type 1 diabetes incidence is significantly reduced in specific
pathogen-free males compared to females, there is no such effect in germ-free males and
females (90). Thus, gender bias in autoimmunity may be influenced by microbiota.
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Moreover, the alpha diversity is higher in females than males, and males have more
abundant Lactobacillaceae compared to females or castrated mice (89, 90). Here we show
that increases in bacterial beta diversity are in agreement with the increased abundance of
Akkermansia muciniphila by dietary Se deprivation or aging in males.
Changes in metabolic functionality and fermentative activities in the colonic
microflora are assessed by analysis of SCFA in feces. Since the vast majority (ca. 95 to
99%) of SCFA and other fermentation products formed by intestinal bacteria are
absorbed from the gut or metabolized by the microbiota, an abundance of SCFA in the
feces indicates production by microflora at levels far above the absorption rate. Previous
research in humans has shown a negative association between aging and the levels of
SCFA (106). Ample evidence also suggests that the gut microbiota may play a role in
obesity by increasing energy-harvesting efficiency of the host, which have increased
amounts of SCFAs in their caecum and reduced energy content in their feces compared
with lean animals (107). In addition, the obese phenotype in mice is transmissible
through microbiota transplants, and germ-free mice colonized with the microbiota from
obese donors gain twice as much fat as those colonized with the microbiota from lean
donors (11). In G3 Terc-/- mice, dietary Se deprivation and aging decrease the body
weight after 15 months of age (105). Overall fecal excretion of SCFA increases with
aging, dietary Se deprivation and sex, which are associated with decreased capacity for
energy harvest in lean animals. Besides, supplementation of L-selenomethionine (SeMet)
or sodium selenite at either 0 or 2 ppm in the presence of wheat bran (WB, 10%) has no
effect on fermentation capacity since the similar levels of SCFAs were found in the rectal
and feces (108). However, we show that dietary Se deprivation influences amount of
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SCFAs. Such seemingly discrepancy may be attributed to differences between mice and
rats or owing to different age, Se species, and duration of dietary Se deficiency.
A key observation made in this study is a dramatic increase in Akkermansia
muciniphila in Se-deprivated or aged males, and this species in females is more adundant
than males regardless of Se status or age. Akkermansia muciniphila is specialized in the
utilization of mucin as a carbon and nitrogen source (98). Analyses of the Akkermansia
muciniphila genome predict a large number of secretory proteins (61, or 11% total
proteins), and they are annotated as glycosyl hydrolases, proteases, sulfatases and
sialidases, and are involved in the degradation of mucin (109). Akkermansia muciniphila
is an emerging key bacterium in the adaptation of the microbiota to dietary nutrient
fluctuation by mucus degradation. In several animal models, a shortage of food-derived
nutrients stimulates the growth of Akkermansia muciniphila (110), indicating that
specialization on endogenous substrates provides a competitive advantage when
exogenous substrates are scarce. Because Akkermansia muciniphila produces
oligosaccharides and SCFAs as a result of mucus degradation, it releases usable energy
for the other intestinal microbes and thus emerges as a key contributor in maintaining the
stability of the gut ecosystem. Akkermansia muciniphila may represent 1–4% of the
microbial community (110) in healthy subjects. In our study, long-term dietary Se
deprivation may chronically stress the mice such that Akkermansia muciniphila is up to
6.7% and energy produced for the host. Moreover, Akkermansia muciniphila can produce
acetate and propionate as a result of mucus degradation (98). These SCFAs are easily
available to the host because they are produced within the mucus layer and at the
proximity of epithelial cells (111). The acetate and propionate produced by Akkermansia28

like bacteria can signal host via the Gpr43 receptor and other SCFAs may also do the
same via Gpr41 (112). A causative role of Akkermansia municiphila in lowering body fat
mass and improving glucose homoeostasis has been shown in mice (113). We show that
SCFAs are increased by dietary Se deprivation and aging, which is positively correlated
with increased abundant of Akkermansia municiphila. Moreover, oligosaccharides and
acetate can stimulate growth and metabolic activity of bacteria that are colonized close to
the mucus layer. This may provide colonization resistance to pathogenic bacteria that
have to cross the mucus layer to reach the intestinal cells. Consistent with this notion, our
results suggest that the abundance of pathogenic bacteria such as Escherichia coli is
reduced by dietary Se deprivation or aging, and this is associated with increased
expression of SCFAs. Moreover, the oral administration of Akkermansia municiphila in
mice had been demonstrated that it can led to increase mucin layer thickness, decrease
metabolic endotoxemia (113), increase number of mucin-producing goblet cells and
increase gut integrity (114). However, in humans, the role of Akkermansia municiphila
remains ambiguous. One study reported that Akkermansia municiphila was more
abundant in subjects with normal glucose tolerance compared with a prediabetic group
(115). The opposite relationship was seen by others, where Akkermansia municiphila was
enriched in patients with type 2 diabetes (T2D) compared with non-diabetic controls
(116). Interestingly, recent studies had found that the antidiabetic drug metformin
treatment in mice on high-fat diet showed an increased relative abundance of
Akkermansia muciniphila compared with non-metformin treatment and also significantly
improved the glycaemic profile (114, 117). In humans, gut microbiome in T2D patients
was modified by the treatments of metformin and showed similar abundance of
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Akkermansia muciniphila compared with control subjects without diabetes, suggesting
that metformin may help ameliorate a type 2 diabetes– associated gut microbiome (118,
119). This discrepancy in humans may be due to differences in T2D patients with the
metformin treatment or not. These results suggest that Akkermansia muciniphila may
repair intestinal inflammation by its ability to increase mucin layer thickness and
increased SCFA related to the long-term selenium deprivation and aging and sex.
Altogether, our results demonstrated changes of gut microbiota in abundance and
composition by dietary Se deprivation; in particular, elevated Akkermansia municiphila
abundance by dietary Se deprivation in males may improve the healthier glucose
metabolism and gut integrity at late stage of old. Interestingly, we found that the females
have higher abundance of Akkermansia muciniphila than males, which is in agreement
with greater survival in females than males.
In conclusion, by using metagenomic sequencing of fecal samples, we find shifts
in microbial composition and SCFA that are correlated with dietary Se deprivation and
aging in both sexes. Furthermore, in our study the elevated mucin-degrading bacterium
Akkermansia muciniphila may play an important role to regulate glucose metabolism in
the gut and reverse dietary Se deprivation-induced metabolic disorders to low the body
fat and decrease intestinal inflammation in mice at the late stage of old. Here, we provide
another potential cause from the microbiota change to explain why the long-term dietary
Se deprivation deteriorates the healthspan but extends the longevity. Take together,
optimizing gut microbiota by nutritionally adequate level of dietary Se appears to
represent a promising strategy to control or prevent early onset of aging and age-related
metabolic diseases.
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2.6

Figures and tables

Figure 2.1

(a) Experimental design. (b) Effect of Se deprivation and aging on the
relative abundances of the four most abundant bacterial phyla (n=6). (c)
Data were pooled from a given treatment group. (d) Box-plot of
Firmicutes/Bacteroidetes ratios in the eight groups.

Box plots display the median, 25th percentile, and 75th percentile; blue dot display
minimum and maximum values; red crosses display mean. *, P < 0.05, compared to Se+
mice. #, P < 0.05, compared to 18 months. Se-, selenium-deficient; Se+, seleniumadequate.
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Figure 2.2

(a) The beta diversity was calculated by principal coordinate analysis
(PCoA) for the visualization of pairwise community dissimilarity (Bray–
Curtis index) of the microbial community. The alpha diversity was assessed
by calculating the (b) Shannon index and (c) Simpson index.

Box plots display the median, 25th percentile, and 75th percentile; blue dot display
minimum and maximum values; red crosses display mean. *, P < 0.05, compared to Se+
mice. #, P < 0.05, compared to 18 months. Se-, selenium-deficient; Se+, seleniumadequate.
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Figure 2.3

Heat map analysis of the pre-dominant genera identified in this study that
significantly separated from the Se-deprivation and aging mice, but not sex.

Color changes from red to green indicate the abundances of bacteria from low to high.
(A: Se+, 18M; B: Se-, 18M; C: Se+, 24M; D: Se-, 24M in Males) (E: Se+, 18M; F: Se-,
18M; G: Se+, 24M; H: Se-, 24M in Females)
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Figure 2.4

Selenium is required by several gram-positive bacteria.

(a) Changes the proportions of gram positive and gram negative bacteria with selenium
deprivation and aging (b) Data were pooled form a given treatment group. Changes in the
three selenoprotein family rich phyla: (c) Clostridia, (d) Acitnobacteria and (e)
Deltaproteobacteria. Box plots display the median, 25th percentile, and 75th percentile;
blue dot display minimum and maximum values; red cross display mean. *, P < 0.05,
compared to Se+ mice. #, P < 0.05, compared to 18 months. Se-, selenium-deficient; Se+,
selenium-adequate.
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Figure 2.5

Gender-specific effects.

(a) Gender-specific differences (P=0.0005) in Akkermansia municiphila were observed in
the total study population with higher levels in females than in males. The relative
abundance of Akkermansia municiphila among the eight group. (b) Quantitative PCR
results of Akkermansia muciniphila. Box plots display the median, 25th percentile, and
75th percentile; blue dot display minimum and maximum values; red cross display mean.
*, P < 0.05, compared to Se+ mice. #, P < 0.05, compared to 18 months. Se-, seleniumdeficient; Se+, selenium-adequate.
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Figure 2.6

SCFA-producing bacteria could help to prevent establishment of some
potentially pathogenic intestinal bacteria.

(a) The quantification of short chain fatty acids (SCFA) in fecal samples showed
significantly increase by Se-deprivation and aging in both sexes. Values are means ±SEs
(n = 17). (b) The relative abundance of pathogenic genera. Box plots display the median,
25th percentile, and 75th percentile; blue dot display minimum and maximum values; red
cross display mean. *, P < 0.05, compared to Se+ mice. #, P < 0.05, compared to 18
months. Se-, selenium-deficient; Se+, selenium-adequate.
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Figure 2.7

The relative abundance of two selected probiotics (Bifidobacterium and
Lactobacillus) be altered by dietary selenium deprivation and aging.

Box plots display the median, 25th percentile, and 75th percentile; blue dot display
minimum and maximum values; red cross display mean. *, P < 0.05, compared to Se+
mice. #, P < 0.05, compared to 18 months. Se-, selenium-deficient; Se+, seleniumadequate.
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6.34 ± 0.08*

6.95 ± 0.20
6.84 ± 0.04
8.03 ± 0.19
6.77 ± 0.23
9.12 ± 0.02

Faecalibacterium
prausnitzii

Roseburia/E. rectale

Escherichia coli

Lactobacillus

Universal (total bacteria)
9.08 ± 0.06

6.45 ± 0.20

7.74 ± 0.08#

2.84 ± 0.06#

6.12 ± 0.15#

Se+ ,24M

9.21 ± 0.21

6.86 ± 0.27

7.38 ± 0.04

6.92 ± 0.07

6.13 ± 0.26

Se- ,18M

8.84 ± 0.05

6.95 ± 0.14

7.91 ± 0.32

7.18 ± 0.08

6.64 ± 0.33

Se+ ,18M

8.85 ± 0.08

6.86 ± 0.20

7.85 ± 0.04

4.35 ± 0.09*

6.25 ± 0.57

Se- ,18M

9.00 ± 0.05

7.01 ± 0.08

7.54 ± 0.16#

5.61 ± 0.10#

6.59 ± 0.22

Se+ ,24M

Female

8.97 ± 0.02

6.47 ± 0.02

7.36 ± 0.34

7.24 ± 0.11

5.57 ± 0.54

Se- ,24M

Values are means ±S.E. (n = 6). *, P < 0.05, compared to Se+ mice. #, P < 0.05, compared to 18 months. Se-, selenium-deficient;
Se+, selenium-adequate

9.11 ± 0.11

6.69 ± 0.26

7.92 ± 0.37

3.63 ± 0.05*

Se- ,18M

Male

Log 16S rDNA gene copies/µL fecal DNA

Quantitative PCR results for bacterial groups.

Bacterial species or group Se+ ,18M

Table 2.1
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CHAPTER III
EVALUATING THE IMPACT OF BEAN FERMENTATION BY INTESTINAL
MICROBIOME ON ADIPOGENESIS
3.1

Abstract
This study was conducted to investigate the effects of bean fermentation by gut

microbiota on adipocyte differentiation and the underlying cellular and molecular
mechanisms. Non-digestible fibers isolated from three cultivars of Phaseolus vulgaris,
also known as common beans, were fermented by fresh mouse feces aerobically. The
murine 3T3-L1 preadipocytes were induced to differentiate and treated with the
fermentation products of common beans for assessment of cell viability, lipid
accumulation, and expression of key transcriptional factors and activators during the 8day time course of differentiation. Analytical results showed that the fermentation
products contained higher levels of total short-chain fatty acid compared to fiber-free
negative control group. Treatment of the fecal fermentation products inhibited adipocyte
differentiation and fat accumulation in a dose- and time-dependent manner. Furthermore,
the fermentation products suppressed the mRNA and protein expression of adipogenesisassociated key transcription factors, peroxisome proliferator-activated receptor γ (Pparγ),
CCAAT/enhancer binding protein α (C/ebpα) and the mRNA expression of fatty acid
binding protein 4 (Fabp4). Interestingly, treatment of the fermentation products enhanced
3T3-L1 cells to express lipolytic genes including peroxisome proliferator-activated
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receptor δ (Pparδ) and mitochondrial uncoupling protein 2 (Ucp2). Taken together, these
results show that fermentation products of non-digestible fibers isolated from common
beans inhibit adipogenesis in association with selective inhibition of adipogenic
transactivators and activation of genes in favor of energy expenditure.
3.2

Introduction
The worldwide prevalence of obesity calls for cost-effective and straightforward

strategies to maintain optimal body weight. Although many weight-loss drugs containing
a single active compound have been developed, they are costly and more or less have side
effects. In this regard, staple foods that contain various forms of fibers and
phytochemicals are considered ideal as they collectively regulate metabolic processes
through dietary approaches from a physiological perspective (120-122).
Convincing lines of evidence from human and animal studies demonstrate
metabolic regulation by gut microbiota. It is known that the abundance of Bacteroidetes
is reduced and Firmicutes is increased in an obese host (9). Such a shift is associated with
increased energy absorption from foods, low-grade inflammation, and storage of liverderived triglycerides (10). The notion that energy extraction by the host increased from
obese gut microbiota is observed in ob/ob obese mice exhibiting a substantial increase in
the expression of enzymes decompose dietary polysaccharides and a reduced calorie
content in the feces (11). Strikingly, transplantation of the microbiota isolated from ob/ob
mice to germ-free healthy mice transfers the obese phenotype (11). Furthermore,
introduction of gut microbiota from conventionally raised mice into germ-free mice
results in increased body fat by 60% and insulin resistance within 2 weeks despite
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reduced food consumption by 29 % and increased activity by 27 % (13). Thus, gut
microbiota play causative roles in the development of obesity.
Phaseolus vulgaris, a legume and largely known as common beans, is grown for
its edible seeds that are nutritious and rich in fibers and other bioactive substances (123,
124). Common beans are an important source of nutrients for more than 300 million
people living in parts of Eastern Africa and Latin America, representing 65% of total
protein consumed, 32% energy needs, and a major source of micronutrients. Dietary
fibers are complex carbohydrates and resistant to the digestion system of humans but
become foods for microbiota in hindgut. Bacterial fermentation generates gases and
short-chain fatty acids (SCFA). Quantity and forms of dietary fiber determine the
composition of gut microbial and profile of SCFA, including acetate, propionate,
butyrate, and a small amount of isobutyrate, valerate, and isovalerate (125, 126).
Catabolism of SCFA provides 60–70% total energy needs of the colonocytes mainly
through butyrate (127) , and propionate is the major gluconeogenic substrate in ruminants
(128) . Furthermore, acetate, propionate, and butyrate are effective in suppressing weight
gain through distinctive pathways (129, 130). While propionate and butyrate can inhibit
food intake through G protein-coupled receptors (131), acetate and butyrate are known to
suppress weight gain and enhance energy expenditure independent of food intake as
evidenced in rodent models of genetic and diet-induced obesity (132-135). Thus,
fermented products of non-digestible fibers of common beans by gut microbiota may
regulate energy metabolism and body weight of the host (136).
Clinical and animal studies have consistently demonstrated efficacies of common
bean consumption on weight loss (137-143). However, how common beans suppress
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obesity is unclear. Considering the established role of gut microbiota in obesity (11, 144,
145), the objective of this study was to determine effect of fecal fermentation products of
non-digestible fibers of common beans on the differentiation of 3T3-L1 preadipocytes
into adipocyte-like cells. Black turtle, pinto, and navy beans were chosen because fiber
content and bioactive compounds in common beans differ by color. Our results
demonstrate that the fermented products inhibit the differentiation into adipocytes and
expression of the adipogenic transcription factors peroxisome proliferator-activated
receptor  (Ppar) and CCAAT/enhancer binding protein α (C/ebpα).
3.3
3.3.1

Materials and methods
Cells, chemicals, and beans
3T3-L1 mouse embryonic fibroblasts (CL-173, American Type Culture

Collection, Manassas, VA, USA) were cultured in Dulbecco’s modified Eagle’s medium
(DMEM, Gibco BRL, Grand Island, NY, USA) containing 10% FBS (Gibco, BRL) and
100 U/mL penicillin-streptomycin (Gibco, BRL) at 37 °C in a humidified 5% CO2
incubator. To induce differentiation into adipocytes, 3T3-L1 cells two days past
confluency were stimulated with MDI solution containing 3-isobutylmethylxanthine (0.5
mM), dexamethasone (1 μM), and insulin (10 μg/mL) for 2 days, followed by
maintenance in DMEM containing 10% FBS and insulin (10 μg/mL) for 6 days when
90% of the cells contained significant intracellular lipid droplets and thus considered as
mature adipocytes. Cell culture medium and the fermented products of non-digestible
fibers were replenished every other day during adipocyte differentiation. Cell viability
was determined by trypan blue exclusion assay (146). All chemicals were purchased from
Sigma (St. Louis, MO, USA) unless indicated otherwise. Three cultivars of Phaseolus
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vulgaris (black turtle beans, lot number:12JD2075; pinto beans, lot number:13DD2508;
navy beans, lot number:13OF2554) were provided by SK Food International (Fargo, ND,
USA). Common beans (50 g) were soaked in water (250 mL) overnight and then boiled
for 1 h. Cooked beans were ground in a grinder, lyophilized, sieved through a stainless
steel 35-mesh (0.5 mm), and stored at -20°C before analyses.
3.3.2

Total dietary fiber
Soluble and insoluble dietary fibers were fractioned following the AOAC method

991.43 (AOAC 2002) with modifications (Figure 3.1). Briefly, 1 g of lyophilized and
sieved bean sample was placed in a flask containing 40 mL of MES-TRIS buffer (pH 8.2)
and completely dispersed by a magnetic stir, followed by addition 0.1 mL of heat-stable
α-amylase (A3306, Sigma, 1 U/mL) and incubation in a water bath at 100°C for 30 min
with low speed stir. The flasks were then cooled to 60°C, added with 0.1 mL of protease
(P3910, Sigma, in 5 mg/mL MES-TRIS buffer), incubated in a water bath at 60°C for 30
min. The samples were then adjusted to pH 4 with 1N HCl at 60 °C, added with 0.3 mL
of amyloglucosidase (A9913, Sigma), incubated in a water bath at 60 °C for 30 min
under constant agitation, and centrifuged (10 min at 5000  g). The supernatant (soluble
dietary fiber) and pellet (insoluble dietary fiber) were collected, freeze-dried, and
weighed. Non-digestible dietary fiber (NDF) was made by combining the lyophilized
soluble and insoluble dietary fibers.
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3.3.3

Resistant starch
Resistant starch was determined as described previously (147). Briefly, NDF (0.1

g) was resuspended in KOH (2 M, 6 mL) under constant agitation for 30 min at 25 °C.
Acetate buffer (0.4 M, 3 mL, pH 4.75) and HCl (2 N, 5 mL) were added and the pH
adjusted to 4.75. Subsequently, amyloglucosidase (60 μL, A9913, Sigma) were added
and incubated in a shaking bath at 60 °C for 30 min, followed by centrifugation at 3000 x
g for 15 min, re-suspension in 10 mL distilled water, and centrifugation. The pellet,
representing resistant starch, was freeze-dried and weighed.
3.3.4

Oligosaccharides
Oligosaccharides were extracted from NDF as previously described with

modifications (148). NDF (10 g) was homogenized in 80% ethanol (100 mL) and placed
in a Soxhlet at 80 ◦C for 60 min. The ethanol extracts were recovered and concentrated
under vacuum. Oligosaccharides in the water phase were frozen, lyophilized, and
quantified using a phenol-sulfuric acid method (149). Briefly, the oligosaccharides were
re-dissolved in deionized water (30 µL, 1 mg/mL), rapidly added and mixed with
concentrated sulfuric acid (150 μL) using a horizontal shaker at 90 °C for 15 min, and
incubated with 5% phenol (30 µL) for 10 min at room temperature. The absorbance of
the sample was measured by using a spectrophotometer at 490 nm (Genesys 10S
UV/VIS, Thermo-Fisher Scientific, Waltham, MA, USA), and expressed as mg raffinose
equivalents/g as compared to the 1-100 mg raffinose standard curve.
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3.3.5

In vitro fermentation
Fermentation of NDF was performed in an anaerobic incubator at 37 °C for 24 h

as previously described (150, 151). Raffinose was used as a control for fiber fermentation
and the fecal inoculum was initiated using fresh stool from healthy mice without
antibiotics intake. Briefly, sterile tubes (15 mL) were filled with 9 mL of sterile basal
culture medium containing (g/L): peptone water, 2 g/L; yeast extract, 2 g/L, NaCl, 0.1
g/L, K2HPO4, 0.04 g/L; KH2PO4, 0.04 g/L; MgSO4•7H2O, 0.01 g/L; CaCl2•2H2O, 0.01
g/L; NaHCO3, 2 g/L; cysteine HCl, 0.5 g/L; bile salts, 0.5 g/L; tween 80, 2 mL/L;
hematin, 0.2 g/L. Fecal slurries were prepared by homogenizing 2 g of fresh stools with
18 mL of 0.1 M sodium phosphate buffer (pH 7.0). The tubes containing basal culture
medium were inoculated with 1 mL of fecal slurries and NDF (100 mg) were added after
inoculation except blanks. The samples were shaken in vortex for 30 s and placed in
OxoidTM anaerobic jar with CO2 gas generation bags (Thermo Fisher Scientific) at 37 °C
for 24 h. Fermentation was stopped by placing the tubes in a freezer at -80 °C. Within 24
h, the frozen fermentation tubes were thawed in warm water and the fermented products
were collected by centrifugation (3,800 x g for 15 min at 4 °C) for immediately analyses
and treatments.
3.3.6

Analysis of SCFA
The in vitro fermented products (200 µl) were acidified with HCl (6 M, 10 µL)

and spiked with ethyl-butyric acid as an internal standard. Samples were kept on ice for 5
min and then centrifuged at 17,000 x g at 4°C for 5 min and the supernatant was
collected. The SCFA composition was measured by gas chromatographic method using a
Thermo Trace-1310 equipped with a TriPlus RSH Autosampler (Thermo Fisher
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Scientific) using a fatty acid phase column (DB-FFAP 125-3237, J&W Scientific,
Agilent Technologies Inc., Santa Clara, CA) as previously described (152).
3.3.7

Oil Red O staining
Cells were washed twice with PBS, fixed with 10% formalin overnight, and then

stained with 0.5% filtered Oil Red O solution (1.8 mg/mL Oil Red O in 60% isopropanol)
for 30 min. Excess Oil Red O solution was removed and cells were washed twice with
distilled water and air-dried. To quantify lipid accumulation, stained lipid droplets were
dissolved in 100% isopropanol, and followed by measurement of light absorption at 510
nm with FlexStation 3 Multi-mode Microplate Reader (Molecular Devices, Sunnyvale,
CA).
3.3.8

Western analyses
Soluble fraction was prepared by lysing cells in ice-cold RIPA buffer containing

protease inhibitors cocktail and sodium orthovanadate (Santa Cruz Biotech, Santa Cruz,
CA) for 30 min, centrifuged at 10,000 x g for 30 min at 4 °C, separated by 12% SDSPAGE, and transferred to PVDF membranes (Millipore Corp., Bedford, MA). The
membranes were blocked with a solution containing 5% bovine serum albumin for 1 h
and then incubated with antibodies against PPARδ (1:1000, ab23673, Abcam, MA),
C/EBPβ (1:1000, ab18336, Abcam), PPARγ (1:200, sc-7273, Santa Cruz Biotech.),
C/EBPα (1:200, sc-61, Santa Cruz Biotech.), and β-actin (1:200, sc-8432, Santa Cruz
Biotech.) at 4 °C for overnight, followed by incubation with HRP-conjugated secondary
antibodies (Santa Cruz Biotech.) for 1 h at room temperature. An enhanced
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chemiluminescence detection kit (Bio-Rad Lab., CA) was used for signal acquisition.
Protein bands were quantified using ImageJ imaging software (NIH).
3.3.9

Quantitative RT-PCR analyses
Total RNA was extracted using RNeasy mini kit (Qiagen, CA, U.S.A.),

quantitated spectrophotometrically (ND-2000, NanoDrop Technologies, Wilmington,
DE), and reverse transcribed (1 µg) into cDNA using SuperScript IV reverse transcriptase
kit (Thermo Fisher Scientific). Real-time qPCR was performed using SYBR Green
Supermix (Bio-Rad Lab., Hercules, CA) and QuantStudio 5 Real-Time PCR system
(Applied Biosystems, Foster City, CA) with the following condition: 95°C, 30 sec; 40
cycles at 95°C, 3 sec; 60°C, 20 sec. Because adipocyte differentiation is a complicated
process involving various morphological, cellular, and molecular changes and even the
expression of reference genes may change under such conditions (153), the average of 4
relatively stable housekeeping genes, including β-actin, ATP synthase H+ transporting
mitochondrial F1 complex beta subunit (ATP-5b), zeta polypeptide of tyrosine 3monooxygenase/tryptophan 5-monooxygenase activation protein (Ywhaz), non-POUdomain containing octamer binding protein (Nono) (154), was employed as an internal
control (Figure 3.2). The primers used in this study were shown in Table 3.4.
3.3.10

Statistical analysis
Data were analyzed by Student’s t-test or one-way ANOVA with time- or dose-

repeated measurements. If there was a main effect, Dunnett’s test was used for post hoc
comparisons of means. Data were analyzed by using GraphPad Prism 6.0 (La Jolla, CA).
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All experiments were performed three times and the level of significance () was set at
0.05 unless otherwise indicated.
3.4
3.4.1

Results
Assessment of fecal fermentation product of NDF isolated from black
turtle, pinto, and navy beans
Seeds of common beans are known to be rich in slowly digested and non-

digestible carbohydrates that can be fermented in the large intestine (155). We followed
the protocol of AOAC 991.43 to isolate NDF, and the results showed that the NDF in
cooked beans were ranged from 47% to 59%, which were similar with many studies
using different cooked common beans by employing the same isolation and measurement
methods (AOAC 991.43) (156-158). Nonetheless, these numbers were higher than the
reported 22% to 26% NDF from 10 cooked Latin America bean cultivars by Granito et al
(159) and. Such differences could be attributed to the additional acidic treatment (adjust
to pH 4.0 with 0.1 N HCl) before the enzymatic digestion of the AOAC 991.43 protocol
as detailed in the Granito et al publication (159). This suggests that the current AOAC
method may need additional step to better reflect stomach digestion in low pH condition
in a physiological perspective. In addition, our numbers were higher than the reported
16% to 20% NDF from 2 common beans as shown in Chang et al (160). Those
differences could be attributed to different cooking solvents of DMSO and water. The
organic solvent may enhance the insoluble fiber to be dissolved into liquid phase and then
decrease the insoluble fiber content compared with cooking in water. Besides, Chang et
al (160) used the extra re-extract step with 0.5% EDTA for insoluble NDF and additional
dialysis for soluble NDF fraction. Therefore, this suggests the further extraction would be
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a better method to collect more specific NDF. While analysis of NDF composition
showed that navy beans contained less total polysaccharides and insoluble fiber and more
oligosaccharides compared to black turtle and pinto beans (Table 3.1), these three beans
had no comparable difference in the amount of soluble fiber and resistant starch, and
greater amount of insoluble than soluble fibers. While fermentation of NDF of common
beans for 24 h enhanced total SCFA concentration and shifted the ratio of
acetate:propionate:butyrate from 55:10:34 to 98:1:1, they did not differ between black
turtle, pinto, and navy beans. The basal SCFA proportion was in agreement with other
reports (151, 161). Fecal fermentation of NDF increased acetate and decreased
propionate and butyrate concentrations (Table 3.2), and their pH values were decreased
but no difference among the three cultivars of common beans (Table 3.3). Thus, fecal
fermentation of NDF of common beans appeared to be effective.
3.4.2

Effect of fermented products of NDF from common beans on lipid
accumulation and proliferation in 3T3-L1 adipocytes
To evaluate potential cytotoxicity and proper doses, 3T3-L1 preadipocytes were

treated with 1.25-10% fermented products of NDF from navy beans for 24 h and they
proliferated normally even at the 10% dosage (data not show). By calculation, 10%
fermented products in liquid form the cell culture being exposed equaled 2 mg of raw
common beans. Thus, this dose is highly achievable when one considers common bean
intake for such anti-adipogenesis effect based cultured cell studies. Nonetheless, it is
necessary to consider individual variations in gut microbiota, personalized gut health, and
differences in vitro and in vivo as such high efficacy of common bean digestions were
made under optimized conditions in vitro and not likely to be reached in vivo. For all the
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experiments, 3T3-L1 preadipocytes were induced to differentiate into adipocytes by
treatments individually with 10% phosphate buffer (non-treatment, NT), fermentation
medium (FM), fiber-free fermented product (FF), and fermented products of black turtle,
pinto, and navy beans every other day for 8 days. Adipogenic differentiation of 3T3-L1
cell was observed with NT, FM and FF treatments and resulted in morphological changes
from fibroblast-like to enlarged, rounded cell shape and of accumulation of lipid bodies
in more than 90% of the cells on Day 8, but cells treated with the bean fermented
products remained fibroblast phenotypes (Figure 3.3A). Quantitative analysis of
adipogenesis by Oil Red O staining showed that treatment of 3T3-L1 cells with any of
the three bean fermented products significantly reduced lipid accumulation compared to
the three control groups (Figure 3.3B). 3T3-L1 cells that were treated the bean fermented
products outnumbered the differentiated adipocytes by 2.4-fold on Day 8 (Figure 3.3C).
Because the inhibitory effects of fermented products on differentiation and lipid
accumulation in 3T3-L1 cells were similar between the beans, only navy beans was
employed for the studies hereafter. Further analyses demonstrated a dose-dependent
effect of the fermented products (1.25-10 %) on the inhibition of adipocyte differentiation
and intracellular lipid droplet formation (Figure 3.4A), lipid accumulation (Figure 3.4B),
and protein expression of C/EBPα and PPARγ (Figure 3.5C), two major transcriptional
factors for adipocyte differentiation.
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3.4.3

The fermented products of NDF inhibit the early phase of adipogenesis in
3T3-L1 cells
Because 3T3-L1 adipocyte differentiation comprised early (Days 0–2), post-

mitotic intermediate (Days 3–4) and terminal stages (after Day 4) (162, 163), we next
assessed temporal events (Figure 3.5A) of adipogenesis inhibition by the fermented
products. Inhibition of adipogenesis (Figure 3.5B), lipid accumulation (Figure 3.5C),
and protein expression of PPARγ and C/EBPα (Figure 3.5D) in 3T3-L1 cells by
treatment in the first 2 days are comparable to those for 4-8 days. Similarly, while such
treatment during the last 2 and 4 days of differentiation (Figure 3.6A) did not impact
adipogenesis, lipid accumulation, and protein expression of PPARγ and C/EBPα,
treatment during the entire process and the last 6 days showed inhibitory effects on these
three parameters of 3T3-L1 preadipocyte differentiation in a time-dependent manner
(Figures 3.6B-4D). These results suggested that inhibition of adipocyte differentiation by
the fermented products of navy beans occurred at the early stage of differentiation.
3.4.4

The fermented products up-regulate mRNA levels of Ppar and Ucp2
during the differentiation of 3T3-L1 adipocytes
While PPARγ and C/EBPα serve as essential transcription factors of adipocyte

differentiation and promote lipid storage (164), PPARδ and UCP2 promotes β-oxidation
and energy uncoupling for burning fat in adipocytes (165-168). Furthermore, C/EBPβ is a
transcription activators of PPAR and C/EBPα (169, 170). Because the inhibitory effect
of the fermented products on adipogenesis occurs during the first two days after
treatment, temporal signaling events 1-24 hours after the treatment were assessed. Results
from Western analysis showed that while levels of C/EBPα, C/EBPβ, PPAR, and
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PPAR protein were elevated in the early stage adipogenesis, treatment of 3T3-L1 cells
with the fermented products attenuated the protein expression of C/EBPα and PPAR. In
contrast, level of C/EBPβ protein did not differ by the treatment of fermented products
during the first 24 hours, and PPAR protein was increased at 6 and 24 hours after the
treatment (Figure 3.7). Results from an 8-day time course study (Figure 3.8A) showed
that the fermented products inhibited PPAR and C/EBPα, activated PPAR, or did not
impact C/EBPβ protein expression (Figures 3.8B and 3.8C). To confirm such
stimulatory effects of the fermented products on PPAR protein expression, results from
qPCR analyses demonstrated up-regulation of Ppar and Ucp2 mRNA at day 3 (Figures
3.9C and 3.9D), suggesting energy expenditure promotion by the fermented products of
NDF. Furthermore, mRNA levels of Ppar and Fabp4, two genes encoding master
regulators of adipogenesis (171), were increased during adipogenesis, but dramatically
reduced 8 days after treatment with the fermented products (Ppar , 7-fold; Fabp4, 52fold) (Figures 3.9A and 3.9B). Altogether, the fermented products of NDF suppress
adipogenesis in 3T3-L1 cells not only by inhibition of adipogenesis but also activate
energy expenditure through β-oxidation.
3.5

Discussion
In common beans, seeds contain slow digestible carbohydrates and a high

proportion of non-digestible carbohydrates that are fermented in the large intestine (155).
We found that the content of oligosaccharides was significantly highly in navy beans than
black turtle and pinto beans. The higher oligosaccharide content in cooked navy bean was
probably due to increased soft texture of navy bean that was not only easy to cook but
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also higher leaching of soluble components such that more bound oligosaccharides were
released during cooking (172). It has also been reported that bound oligosaccharides go
through non-enzymatic hydrolysis and release oligosaccharides from bound
macromolecules during cooking, resulting in an increase in oligosaccharide content
(173). The capacity of oligosaccharides to stimulate the growth of bifidobacteria and
lactobacillus in vitro and the production of SCFAs (mainly acetate, propionate, and
butyrate) by fermentation has been linked to their prebiotic effect (174). Therefore, we
suggest that cooked navy beans might be an excellent source of oligosaccharides for
bacteria’s fermentation. The insoluble fibers usually demonstrate a mechanical action on
the gastrointestinal tract, such as an increase in fecal volume. Conversely, the soluble
fibers have metabolic effects, especially the viscous ones. They are known to optimize
blood glucose and insulin concentrations after feeding and decrease serum cholesterol,
together with increased fecal losses of bile acids. These effects appear to be related to the
viscosity, and, in general, these forms of fibers have little effect on fecal volume because
they are rapidly fermented by the colonic microbiota, producing SCFAs and gases.
Although ample evidence supports regulatory roles of gut microbiota in obesity
and SCFA formation by fermentation of NDF (130, 131, 175-177), how fecal
fermentation of NDF of common beans counteracts adipogenesis is unknown.
Differentiation of preadipocytes undergoes morphological and biochemical transitions
from growth arrest of confluent preadipocytes, re-entry into the cell cycle with several
rounds of post-confluent mitosis, and terminal differentiation into mature adipocytes with
changes in genetic programs for lipid synthesis and storage (178). Consistent with the
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notion proposed before (179), treatment with the fermented product during the first 2
days is sufficient to offer nearly full suppression as opposed to the 8-day time course.
As illustrated in Figure 3.10, the results presented here demonstrate that fecal
fermentation product of NDF of common beans suppresses adipogenesis and an early
transcription factor Ppar and nuclear receptor C/ebpα expression and stimulates genes
promoting energy expenditure (Ppar and Ucp2) in 3T3-L1 cells. Temporally, the fecal
fermentation products of common beans inhibit C/EBPα and PPAR expression at the
turn of differentiation as early as 1day post-treatment, followed by FABP4 expression
during adipocyte maturation. The fecal fermentation product does not impact the
expression of C/EBPβ, a transactivator of PPARγ (180), suggesting that it may intervene
the transcriptional activation of PPAR. Because the fermented products did not impact
C/EBPβ protein expression during the entire time course (Figure 3.8C), the inhibition of
PPARγ and C/EBPα expression might not be attributed to C/EBPβ in the differentiation
of 3T3-L1 cells. In contrast, the fermented product stimulates the expression of PPAR
during the initiation of adipocyte differentiation as well as UCP2 during adipocyte
maturation.
The efficacy of our fecal fermentation of NDF from common beans is evidenced
by a 1.4-fold increase in total SCFA content and lowered pH value. Acetate, propionate
and butyrate are major SCFA produced by fecal bacterial fermentation and typically
exhibit a molar ratio of about 60:20:20 (181), but this varies by NDF, microbiome
diversity and activity, and gut transit time (125, 182). We found that fecal fermentation of
NDF from common beans greatly increases acetate content (98%) and decreases
propionate and butyrate abundance. Acetate is known to suppress appetite through
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increased expression of leptin in adipocytes (182, 183) and enhance energy expenditure
through inhibition of fatty acid synthesis and activation of fatty acid oxidation (134, 135,
184). However, it is unclear whether acetate confers the effect of fecal fermentation
products of NDF on adipocyte differentiation and maturation.
An apparent question is: Why the fecal fermentation product of common beans
inhibit expression of certain key factors of adipogenesis yet promote others? Key players
in the signaling of differentiation and maturation of adipocytes include the early
transcription factors C/EBPβ and C/EBPα and the nuclear receptor PPARγ (185). In light
of the presence of C/EBP binding sites on PPARγ promoter (169, 180), it is puzzling why
C/EBPα but not C/EBPβ expression is greatly inhibited by the fecal fermentation product
of common bean NDF. C/EBPβ is the likely link between mitotic clonal expansion and
can also transcriptionally activate C/EBPα (170). Thus, it is of future interests to
determine whether the reduced PPAR expression in the presence of fermented product
of NDF of common beans is attributed a hampered transactivation effect of C/EBPβ on
C/EBPα. This also helps to explain the dramatic down-regulation of FABP4 as it is
known to be downstream of PPARγ and C/EBPα. In contrast, UCP2 and PPARδ that are
involved in β-oxidation or energy expenditure are up-regulated by treatment with the
fermented products during adipogenesis. The expression of PPARδ, which participates in
β-oxidation reaction and is directly involved in fatty acid breakdown (166), was
significantly increased in the early stage. UCP2 participates in triglyceride-specific
hydrolysis and PPARδ plays an important role in lipid metabolism.
In conclusion, our data suggest that the beneficial effects of fecal fermentation of
the non-digestible fiber from common beans in counteracting adipogenesis are related to
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suppression of the adipocyte differentiation. The study provides interesting insights into
how the fermented products, mainly SCFA, of NDF of common beans intervene obesity
through regulations of adipogenesis and energy expenditure. First, the fermented products
suppress C/EBPα and PPAR the early differentiation stage and FABP4 during adipocyte
maturation. Second, the fermented products also activate the expression of PPARδ and
UCP2 to enhance energy expenditure in 3T3-L1 cells. Results from these molecular
analyses implicate common bean consumption as a cost-effective and powerful approach
to counteract adipogenesis. It is of future interests to understand physiological impact of
common bean consumption in animal models of obesity. Furthermore, identification of a
key or a group of bioactive compounds that confer the efficacy of the fermented products
of NDF of common beans would be helpful to further explore new candidates targeting
adipogenesis and energy expenditure.
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3.6

Figures and tables

Table 3.1

Non-digestible fiber composition in three lyophilized common beans

1

Black bean

Pinto bean

Navy bean

Non-digestible fiber (%)#

53.54±0.82a

59.25±0.27a

47.30±0.45b

Insoluble fiber (%)#

42.85±1.55a

47.67±1.20a

35.30±0.91b

Soluble fiber (%)#

10.69±2.37

11.58±1.47

12.00±0.45

Resistant starch (%)*

25.15±3.60

23.30±1.84

30.45±3.25

Oligosaccharides (mg/g)*

45.47±0.88b

38.01±0.84c

61.16±0.29a

1
#

Values are means ± SDs (n = 3) and differ (P < 0.05) without a common letter.

, Percent lyophilized beans by weight. *, Percent or milligram raffinose equivalence per
gram of the isolated polysaccharides.

Table 3.2

Short-chain fatty acid concentrations (mmol/L) after one day in vitro
fermentation of non-digestible fibers of common beans by mouse feces1
Fiber-free

Black bean

Pinto bean

Navy bean

Acetate

5.73±0.20

23.33±1.65*

23.44±1.08*

22.32±0.85*

Propionate

1.05±0.04

0.21±0.01*

0.21±0.04*

0.25±0.01*

Butyrate

3.52±0.13

0.22±0.02*

0.25±0.02*

0.24±0.02*

Total SCFA

10.30±0.36

23.76±1.63*

23.9±1.08*

23.13±0.83*

Ratio

55 : 10 : 34

98 : 1 : 1

98 : 1 : 1

98 : 1 : 1

1

Values are means ± SDs (n = 3). Ratios stand for percent acetate: propionate: butyrate.
*, P < 0.05, compared with fiber-free control.
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Table 3.3

pH values after fermentation by mouse feces

1

Fiber

Fiber-free

Fiber-free

Raffinose

Black bean

Pinto bean

Navy bean

Feces

-

+

+

+

+

+

7.6±0.1

7.7±0.2

3.8±0.2*

4.2±0.1*

4.2±0.1*

4.4±0.1*

pH
1

Values are means ± SDs (n = 3).
*, P < 0.05, compared with fiber-free or feces control.

Table 3.4

The primers used in qRT-PCR

Gene

Primers sequence (5’→3’)

Amplicon size (bp)

Pparγ

F: TCATCTCAGAGGGCCAAGGATTCATG
R: TGCAGCAGGTTGTCTTGGATGTCCTC

226

Fabp4

F: TGAAATCACCGCAGACGACA
R: ACACATTCCACCACCAGCTT

141

Ucp2

F: ACTTCACTTCTGCCTTCGGG
R: GGAAGGCATGAACCCCTTGT

226

Pparδ

F: CTGTGCAGACCTCTCCCAGAAT
R: CATACTCGAGCTTCATGCGG

203

β-actin

F: GCCACTGTCGAGTCGCGTCCACC
R: ATTCCCACCATCACACCCTGGTGCC

219

Nono

F: TGCTCCTGTGCCACCTGGTACTC
R: CCGGAGCTGGACGGTTGAATGC

170

Ywhaz

F: AAAAACAGCTTTCGATGAAGCC
R: GCCGGTTAATTTTCCCCTCC

168

Atp-5b

F: TGGCTCAGAGGTGTCTGC
R: TCAGTCAGGTCATCAGCAGG

165
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Figure 3.1

A diagram for the preparation of various samples from common beans for
food, biochemical, and cellular analysis.
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Figure 3.2

Distribution of qPCR quantification cycle values for the reference genes.

qPCR gene expression analysis was carried out on cDNA derived from cells treated with
controls (Ctl) and fermented products (FP) of none-digestible fiber isolated form
common beans. Values of quantification cycle (Cq) were determined for the expression
of β-actin, Atp5b, Ywhaz and Nono reference genes. Data are expressed as means ± SDs
(n = 3).
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Figure 3.3

Effect of fermented product of non-digestible fibers isolated from common
beans on lipid accumulation and proliferation in 3T3-L1 cells.

The pre-adipocytes were induced to differentiate into adipocytes together with
administration of non-treatment (NT), 10% fermentation medium (FM) and fiber-free
(FF), black turtle bean, pinto bean, and navy bean fermented products every other day for
8 days, followed by microscopic observation of the cells (A), Oil Red O staining and
spectrophotometric quantification at 490 nm (B), and determination of proliferation by
trypan blue assay (C). Values are means ± SDs (n = 3). *, P < 0.05, compared to no
fermented product control.
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Figure 3.4

Dose-dependent effect of the fermented product of non-digestible fiber
isolated from navy beans on lipid accumulation and the expression of
differentiation markers in 3T3-L1 cells.

The pre-adipocytes were induced to differentiate into adipocytes together with
administration of non-treatment (NT), 10% fiber-free (FF) and 1.25-10% navy bean
fermented products every other day for 8 days, followed by microscopic observation of
the cells (A), Oil Red O staining and spectrophotometric quantification at 490 nm (B),
and Western analyses of the indicated transcription factors for differentiation (C).
Representative Western blotting imagines were displayed and values were normalized
with their respective β-actin controls. C/EBPα contains two isoforms (30 kDa and 43
kDa) and PPARγ exists in two protein isoforms (54 kDa and 57 kDa) which are different
in the lengths of the N-terminal. Similar to publications by others, the commercially
available C/EBPα antibody yields non-specific bands between to two specific bands at 30
and 43 kDa. Both Values are means ± SDs (n = 3). *, P < 0.05, compared to no
fermented product control.
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Figure 3.5

Time-dependent effect at the early stage adipogenesis of the fermented
product of non-digestible fiber isolated from navy beans on lipid
accumulation and the expression of differentiation markers in 3T3-L1 cells.

The pre-adipocytes were induced to differentiate into adipocytes together with
administration of non-treatment (NT), 10% fiber-free (FF) and navy bean fermented
products every other day beginning from day 0 for 2, 4, 6, or 8 days (A). Representative
microscopic pictures of the cells at day 8 were shown (B). Oil Red O staining and
spectrophotometric quantification at 490 nm (C) and Western analyses of the indicated
transcription factors for differentiation (D) were determined at day 8. Representative
Western blotting imagines were displayed and values were normalized with their
respective β-actin controls. Values are means ± SDs (n = 3). *, P < 0.05, compared to no
fermented product control.
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Figure 3.6

Time-dependent effect at the late stage adipogenesis of the fermented
product of non-digestible fiber isolated from navy beans on lipid
accumulation and the expression of differentiation markers in 3T3-L1 cells.

The pre-adipocytes were induced to differentiate into adipocytes together with
administration of non-treatment (NT), 10% fiber-free (FF) and navy bean fermented
products every other day beginning from last 2, 4, 6 or 8 days (A). Representative
microscopic pictures of the cells at day 8 were shown (B). Oil Red O staining and
spectrophotometric quantification at 490 nm (C) and Western analyses of the indicated
transcription factors for differentiation (D) were determined at day 8. Representative
Western blotting images were displayed and values were normalized with their respective
β-actin controls. Values are means ± SDs (n = 3). *, P < 0.05, compared to no fermented
product control.
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Figure 3.7

Effect of fermented product of non-digestible fiber isolated from navy
beans on the expression of adipogenic protein during the first 24 h of
differentiation.

3T3-L1 preadipocytes were incubated in differentiation medium in the presence or
absence of 10% navy bean fermented product, and the cells were harvested at 0, 1, 2, 4, 6
and 24 h for Western analyses of C/EBPα, C/EBPβ, PPARγ, and PPARδ. Representative
Western blotting images were displayed and values were normalized with their respective
β-actin controls. Values are means ± SDs (n = 3). *, P < 0.05, compared to no fermented
product control.
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Figure 3.8

Effect of the fermented product of non-digestible fiber isolated from navy
beans on the protein expression of four transcription factors during
adipocyte differentiation.

3T3-L1 pre-adipocytes were induced to differentiate by adding the MDI solution
(detailed in materials and methods) in the absence (control) or presence of 10%
fermented product of navy non-digestible fiber and cells were collected 0-8 days
thereafter (A) for Western analyses of C/EBPα, C/EBPβ, PPARγ, and PPARδ.
Representative blots were displayed (B). Values were normalized with their respective βactin controls and are means ± SDs (n = 3) (C). *, P < 0.05, compared to control.
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Figure 3.9

Effect of the fermented product of non-digestible fiber isolated from navy
beans on the mRNA expression of Fabp4 (A), Pparγ (B), Pparδ (C), and
Ucp2 (D) during adipocyte differentiation.

3T3-L1 pre-adipocytes were induced to differentiate in the absence (control) or presence
of 10% fermented product of navy non-digestible fiber and cells were collected at day 0,
3, and 8 for qRT-PCR analyses. Values were normalized with their respective control
using an average of four reference genes (β-actin, Atp5b, Ywhaz and Nono) and are
means ± SDs (n = 3). *, P < 0.05, compared to control.
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Figure 3.10

A scheme depicting the proposed mechanism by which the fermented
product of non-digestible fiber of common beans inhibits adipogenesis and
differentiation of 3T3-L1 pre-adipocytes.
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CHAPTER IV
CONCLUSIONS
The over research aim of this dissertation was to understand whether and how the
dietary Se and fecal fermentation of non-digestible fiber of common beans interact with
mircobiota to optimize health aging and age-related degeneration. The only published
paper on Se and gut microbiota demonstrates the importance of this mineral in microbial
abundance and profile in gut of mice (86); however, the effects of aging and sex on Se
regulation of gut microbiota are not known. Indeed, there are differential effects of sex or
sex hormones on gut microbiota (89, 90). We have recently shown that dietary Se
deprivation in mice carrying humanized telomeres displays type-2-diatetes like symptoms
and other age-related degeneration (105). In my dissertation study, we provide gut
microbiota evidences strongly suggesting that dietary Se deprivation accelerates agedependent changes in abundance, diversity and composition of gut microbiota. Besides,
the shifts in microbial composition and SCFA are correlated with dietary Se deprivation
and aging in both sexes. In particularly, the elevated abundance of Akkermansia
muciniphila, a mucin-degrading and SCFA-producing bacterium, may play an important
role to improve the glucose metabolism in the gut and decrease intestinal inflammation
by long-term dietary Se deprivation and aging. Despite awaiting experimental
verification, it is plausible that long-term dietary Se deprivation deteriorates healthspan
yet increases longevity through gut microbiota in the mice. Furthermore, this can be
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treated using a model system closer to humans such as pigs to study whether
Akkermansia muciniphila can recover the dietary Se deprivation-induced metabolic
disorders and improve age-related degeneration.
The health benefits of consuming plant fiber have long been appreciated.
Epidemiological studies have shown an inverse relationship between dietary plant fiber
and the risk of a couple of age-related degenerations, including obesity and type-2
diabetes. Gut microbes are thought to play an important role in these linkages. Two
recent papers by David et al.(186) and De Vadder et al. (187) demonstrate that ingestion
of plant fiber induces rapid shifts in the composition and function of the gut microbiota
and that metabolites produced by the microbiota support metabolic health by regulating
glucose control in the host. Despite continuous interest in the fiber as a rich source of
therapeutic and preventive compounds against many diseases, few studies have evaluated
the direct effects of fermented products from non-digested fiber on adipogenesis. My
dissertation study has demonstrated that fermented products of non-digestible fiber from
common beans exerted a beneficial effect on lipid metabolism to prevent adipogenesis by
attenuating adipogenic differentiation. The study provides interesting insights into how
the fermented products, mainly SCFA, may favorably against obesity. Further
characterization shows that the fermented products inhibit the adipogenesis of 3T3-L1
preadipocytes by down-regulating many genes associated with lipid accumulation during
the differentiation of 3T3-L1 cells and up regulating the genes involved in lipolysis.
Thus, we suggest that fermented products exhibit anti-adipogenic activities through
modulating the differentiation phase and therefore could be a potential candidate in the
prevention and attenuation of lipid accumulation in adipose tissue. However, further
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studies are needed to confirm the protective role of common beans in vivo using dietinduced or genetic animal models of obesity.
Take together, optimizing gut microbiota by consuming nutritionally adequate
level of dietary Se and non-digestible fiber of common beans appears to represent a
promising strategy to control or prevent early onset of aging and age-related metabolic
diseases.
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Abbreviated

Full Name

AD

Alzheimer’s disease

AMPK

Adenosine monophosphate-activated protein kinase

C/ebpα

CCAAT enhancer-bind protein α

DIO

Dodothyronine deiodinases

Fabp4

Fatty acid binding protein 4

FP

Fermented product

GIP

Glucose-dependent insulintropic polypeptide

GPX

Glutathione peroxidases

LPS

Lipopolysaccharides

NDF

Non-digestible fiber

PD

Parkinson’s disease

Pparγ

Peroxisome proliferator-activated receptor γ

Pparδ

Peroxisome proliferator-activated receptor δ

SBP2

SECIS-binding protein 2

SBP2

SECIS-binding protein 2

SCFA

Short-chain fatty acid

Se

Selenium

SECIS

Selenocysteine insertion sequence

SELENOH

Selenoproteins H

SELENOI

Selenoproteins I

SELENOK

Selenoproteins K

SELENOM

Selenoproteins M

SELENON

Selenoproteins N

SELENOO

Selenoproteins O

SELENOP

Selenoproteins P

SELENOT

Selenoproteins T

SELENOS

Selenoproteins S

SELENOV

Selenoproteins V
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SELENOW

Selenoproteins W

SEPHS2

Selenophosphate synthetase-2

SEPSECS

Selenocysteine synthase

T2D

Type 2 diabetes

TRSP

Selenocysteinyl tRNA

TXNRD

Thioredoxin reductases

Ucp2

Uncoupling protein 2
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